HealthQuad, a healthcare venture capital fund, has announced the final close of its second fund, HealthQuad Fund-II, with a total subscription of US $162 million (INR 1,215 crore), more than 2.2 times greater than its target size at launch.

MSD, the global biopharmaceutical company, led commitments from global financial investors, strategic institutions in pharma and healthcare, development financial institutions (DFI), funds of funds and large European conglomerates. The diverse investor base includes Ackermans & van Haaren (AvH), Teachers Insurance and Annuity Association of America (TIAA), Quilvest, HCL Corporation, DFIs such as CDC, Swedfund and SIDBI and India's leading banking services company.

HealthQuad is an Indian healthcare VC fund that invests in disruptive healthcare models, typically using technology to achieve reach, scale as well as impact. It is backed by Quadria Capital, a leading healthcare-focused private equity fund in Asia, and KOIS, a global pioneer in impact investing and innovative finance. Quadria and KOIS provide an ecosystem of sector knowledge, network, brand, commercial synergies and market access.

HealthQuad Fund-II is investing in 10 - 15 young private companies across high-growth segments of the healthcare sector in India, aiming to generate value as well as achieve deep social impact.

Charles-Antoine Janssen, Co-founder and Chief Investment Officer of HealthQuad, said, "The close of our second fund marks a significant step for HealthQuad as we continue to invest in one of the world's most promising healthcare markets. India's healthcare industry is compounding at 20% growth rate and is likely to be a US $ 372 billion industry by end of this year. The new-age innovative models are fuelling the rise of the Indian health-tech market which is growing at 25% annually and is poised to reach US $ 21 billion by 2025.  We are energised by the vision our Global Investors (LPs) share with us of a flourishing and evolving Indian healthcare ecosystem that answers the needs of the people across all income segments while generating attractive financial returns.”

MSD's investment builds on the company's longstanding presence in India, where it reaches millions of people with its health products.

Carmen Villar, VP Social Business Innovation at MSD, said, "At MSD we are committed to advancing health equity globally through our impact investing portfolio. Our investment in HealthQuad will contribute to a robust and sustainable healthcare ecosystem through innovative solutions in financial inclusion, patient engagement, and supply chain, in India and around the world."

To date, over US $ 60 million of HealthQuad Fund-II has already been deployed in some of the most dynamic, high growth and disruptive companies in each of the sub segments of the healthtech ecosystem. These investments include Medikabazaar, India's largest digital platform for medical supplies and consumables, THB, the leading clinical data aggregation and intelligence platform, Stanplus, the leading tech-enabled Emergency Response System company, Ekincare, the leading tech-led corporate wellness platform, Impactguru, India's leading integrated healthcare financing platform, Qure.ai, the leading AI company focused on radiology and HealthifyMe, India's leading digital wellness company.